CUE - CIK 0001645460
The table below shows Cue Biopharma, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $27.14M | $22.46M | $48.51M | $51.61M | $64.37M | $74.87M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $5.55M | $945.00K | $1.70M | $57.25K | $3.14M | $1.42M |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $36.98M |
| $25.14M |
| $51.45M |
| $77.19M |
| $68.47M |
| $87.53M |
| Property, plant & equipment | $241.00K | $471.00K | $795.00K | $1.50M | $2.11M | $2.11M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $42.21M | $32.19M | $61.53M | $91.28M | $83.40M | $99.53M |
| Accounts payable | $3.95M | $2.82M | $3.50M | $2.73M | $2.59M | $2.07M |
| Total current liabilities | $13.49M | $13.69M | $17.08M | $11.55M | $12.79M | $16.32M |
| Long-term debt | - | $0.00 | $4.20M | $8.03M | - | - |
| Total liabilities | $15.78M | $14.69M | $24.45M | $25.60M | $17.91M | $20.62M |
| Retained earnings | -$368.47M | -$341.86M | -$301.19M | -$250.46M | -$197.45M | -$153.29M |
| Total equity | $26.43M | $17.50M | $37.09M | $65.68M | $65.49M | $78.91M |